Certificate in Travel Health, International Society of Travel Medicine
Medical Licenses
North Carolina #2021-02438, active
Washington #61537210, active
Florida # ME82074, active
Indiana # 0182980A, active
Ohio # 35.137528, active
D.C., Maryland, California, Louisiana, inactive
DEA license, active
Hospital Privileges
HCA Mission Hospital, Asheville, NC, Nov 2021 to present
Cape Canaveral Hospital, Cape Canaveral, FL, June 2020 to Sept 2021
Viera Hospital, Melbourne, FL, June 2020 to Sept 2021
Palm Bay Hospital, Palm Bay, FL, 2004 to Sept 2021
Holmes Regional Medical Center, Melbourne, FL, 2001 to Sept 2021
Faculty Appointments
Volunteer Faculty Member, University of Central Florida College of Medicine, Department of Medical Education Orlando, FL, 2008-2022
Assistant Professor of Medicine, Uniformed Services University of the Health Sciences F. Edward Hebert School of Medicine, Bethesda, Maryland, 1999-2001
Military Service
Lieutenant Commander, Medical Corps, U.S. Naval Reserve, 1993-2001, Honorable Discharge
Navy and Marine Corps Commendation Medal
Professional Society Memberships
American College of Physicians, Fellow
Infectious Diseases Society of America
International Society of Travel Medicine
HIV Medicine Association
Armed Forces Infectious Diseases Society
Bibliography
Increasing Incidence of Penicillin-Resistant Streptococcus pneumoniae (abstract). AJ Barile, TJ Driscoll, DR Harley, RL Haberberger, and MR Wallace. 35th Annual Meeting of the Infectious Diseases Society of America, San Francisco, California, September 1997.
The Changing Epidemiology and Incidence of Methicillin Resistant Staphylococcus aureus (abstract). AJ Kallen, AJ Barile, RL Haberberger, and MR Wallace. 35th Annual Meeting of the Infectious Diseases Society of America, San Francisco, California, September 1997.
Prevalence of HIV-1 Resistance Mutations in a U.S. Military Cohort of Antiretroviral-Naïve Recent Seroconvertors (abstract). AJ Barile, JR Mascola, SA Tasker, RA Shaffer, DD Richman, And SK Brodine. 12th World AIDS Conference, Geneva, Switzerland, June 1998.
Incidence of Postoperative Infection or Positive Culture after Facial Laser Resurfacing: A Pilot Study, a Case Report, and a Proposal for a Rational Approach to Antibiotic Prophylaxis. E. Ross, E. Amesbury, A. Barile, L. Proctor-Shipman, B. Feldman. J. Am. Academy Dermatology, December 1998; 39:975-81.
Fatal Group B Streptococcal Meningitis in a Previously Health Young Adult. A. Barile, A. Kallen, M. Wallace. Clinical Infectious Diseases, January 1999; 28:151.
High Frequency of Antiretroviral Drug Resistance in HIV-1 from Recently Infected Therapy-Naïve Individuals (abstract). S. Wegner, J. Mascola, A. Barile, N. Aronson, G. Martin, K. Stephan, S. Brodine, S. Tasker, S. Bloor, J. Vingerhoets, K. Hertogs, and B. Larder. 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, January 1999.
Drug Resistance Patterns, Genetic Subtypes, Clinical Features and Risk Factors in Military Personnel with HIV-1 Seroconversion. S. Brodine, R. Shaffer, M. Starkey, S. Tasker, J. Gilcrest, M. Louder, A. Barile, T. VanCott, M. Vahey, F. McCutchan, D. Birx, D. Richman, J. Mascola. Annals of Internal Medicine 1999; 131: 502-6.
Lack of Baseline Variability of Antivirogram Phenotypic Assay for Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance (abstract). S. Wegner, A. Barile, K. Stephan, C. Hawkes, P. Dehertogh, R. Garner, B. Larder, K. Hertogs. 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, January 2000.
Prevalence of Genotypic and Phenotypic Resistance to Antiretroviral Drugs in a Cohort of Therapy-Naïve HIV-1 Infected U.S. Military Personnel. S. Wegner, S. Brodine, J. Mascola, S. Tasker, R. Shaffer, M. Starkey, A. Barile, G. Martin, N. Aronson, W. Emmons, K. Stephan, S. Bloor, J. Vingerhoets, K. Hertogs, B. Larder. AIDS 2000; 14: 1009-15.
Clinical Impact of Baseline Genotypic Resistance (abstract). S. Wegner, S. Brodine, S. Wegner, N. Aronson, A. Barile, K. Stephan, M. Wallace, C. Tamminga, J. Wesner, B. Larder, J. Mascola. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 2001.
Racial Differences in Clinical Efficacy of Efavirenz-Based Antiretroviral Therapy (abstract). S. Wegner, M. Vahey, M. Wallace, N. Aronson, A. Barile, W. Emmons, S. Frazier, K. Stephan, M. Nau, S. Piscitelli, R. Harrigan, and B. Larder. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, February 2002.
Diverse HIV Subtypes and Clinical, Laboratory, and Behavioral Factors in a Recently Infected U.S. Military Cohort. S. Brodine, M. Starkey, R. Shaffer, S. Ito, S. Tasker, A. Barile, C. Tamminga, K. Stephan, N. Aronson, S. Fraser, M. Wallace, S. Wegner, J. Mascola. AIDS 2003; 17(17): 2521-2527.
Mechanisms for Linezolid-Induced Anemia and Thrombocytopenia. Bernstein, WB, Trotta, RF, Rector, JT, Tjaden, JA, Barile, AJ. Annals of Pharmacotherapy. 2003 Apr; 37 (4):517-20.